Contract researcher and MRI contrast agent developer Luna Innovations has tame IPO

The nanotech world saw another initial public offering of sorts on Friday when Virginia-based start-up Luna Innovations began trading on the NASDAQ under the symbol LUNA. Why “of sorts?” Although sometimes cited as a “nanotech IPO,” relatively little of Luna’s business is concerned with nanotechnolo...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

The rise of resale continues as Etsy buys Depop for $1.6 billion

News Commentary | June 03, 2021

Resale is proving to be an upward trend, as consumers are looking at secondhand or pre‑loved clothes as a means of being sustainable. Here, Etsy is entering the resale space and capturing a Gen‑Z consumer base by acquiring Depop, a consumer‑to‑consumer apparel marketplace. This news further adds to ... Not part of subscription

Zymergen plunges 68% – materials development hard as usual

News Commentary | August 06, 2021

Zymergen went public on Earth Day this year and promised to generate sales of its first product, Hyaline, in H2 2021. Now it has pushed the target to 2022, and apparently, the public market has not responded well. As discussed in the key issue section of Genomatica's profile, Zymergen is essentially... To read more, click here.

Sequoia's new fund structure is good deal for investors; impact for entrepreneurs or corporate innovators is TBD – but likely not large

News Commentary | October 26, 2021

Famed venture firm Sequoia Capital is reorganizing to have one open‑ended parent "Sequoia Fund" over a variety of subfunds, some of which will remain typical closed‑ended venture funds while others invest in public markets or assets like crypto or pursue new models like registered investment ... To read more, click here.